19:59 , Jun 15, 2018 |  BC Week In Review  |  Financial News

Immunovia issues $37.3M in new shares

Diagnostic company Immunovia AB (SSE:IMMNOV) raised SEK324.4 million ($37.3 million) on June 8 in a new share issue of 2.2 million shares at SEK150. Investors included Swedbank Robur, Handelsbanken Fonder, Alfred Berg Kapitalförvaltning, Nyenburgh Investment...
23:00 , Apr 4, 2017 |  BC Extra  |  Financial News

Isofol raises SEK430M in IPO

Isofol Medical AB (SSE:ISOFOL) lost SEK2 to SEK27 in its first day of trading Tuesday after raising SEK430 million ($48 million) through the sale of 14.8 million shares at SEK29 in an IPO underwritten by...
02:02 , Jan 28, 2006 |  BC Extra  |  Financial News

Genmab raises $119.5 million

Genmab (CSE:GEN) raised DKK735 million ($119.5 million) through a private placement of 5 million shares at DKK147, which was GEN's closing price on Thursday. Merrill Lynch; Alfred Berg; and ABN AMRO Rothschild managed the placement....
08:00 , Dec 12, 2005 |  BioCentury  |  Finance

Ebb & Flow

Even after this month's blowup at...
02:36 , Dec 6, 2005 |  BC Extra  |  Top Story

Zealand withdraws IPO

Five days after issuing its prospectus, Zealand (Glostrup, Denmark) withdrew its planned IPO because it could not obtain a satisfactory price. The company had hoped to list on the Copenhagen Stock Exchange through ABN-AMRO Rothschild/Alfred...
08:00 , Dec 5, 2005 |  BioCentury  |  Finance

Ebb & Flow

IPO activity has been percolating in France, where...
03:41 , Nov 29, 2005 |  BC Extra  |  Financial News

Zealand files for IPO

Zealand (Glostrup, Denmark) filed to sell 4 million shares in an IPO on the Copenhagen Stock Exchange through ABN-AMRO Rothschild/Alfred Berg and Carnegie. Zealand has three compounds in Phase II trials: ZP10 ( AVE0010 ),...
07:00 , Jul 1, 2004 |  BC Extra  |  Financial News

GenMab raises DKK478 million

Antibody company GenMab (CSE:GEN) raised DKK478 million ($78.2 million) through the sale of 5.6 million shares at DKK85 ($13.91) in an international private placement managed by Merrill Lynch; Alfred Berg Bank; and ABN AMRO Rothschild....
07:00 , Jun 21, 2004 |  BioCentury  |  Finance

Ebb & Flow

European investors signaled last week that they will take as hard a line on European IPOs as investors have been taking in the U.S. And given its cash position, the company that tested the waters,...
07:00 , Jun 18, 2004 |  BC Extra  |  Financial News

GenMab plans private placement

Antibody company GenMab (CSE:GEN) plans to sell up to 4.9 million shares in an international private placement. If sold in full at Thursday's close of DKK101 ($16.33), GEN would raise DKK494.9 million ($80 million) prior...